Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.8 USD | -0.52% | -2.00% | +16.97% |
05-02 | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.97% | 323B | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B | |
-2.26% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Gilead, Merck & Co. to Evaluate Lung Cancer Combo Therapy in Two Clinical Studies